Polycythemia laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Line 16: | Line 16: | ||
*B3 Bone marrow biopsy showing panmyelosiswith prominent erythroid and megakaryocytic proliferation | *B3 Bone marrow biopsy showing panmyelosiswith prominent erythroid and megakaryocytic proliferation | ||
*B4 Low serum EPO levels | *B4 Low serum EPO levels | ||
-Polycythemia diagnosed when A1 + A2 any other A or A1 + A2 + any other 2B. RBC indicated red blood cell; Hb, hemoglobin; Ph, Philadelphia; WBC, white blood cell; and EPO, erythropoietin. | |||
==References== | ==References== |
Revision as of 22:17, 12 December 2020
Polycythemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Polycythemia laboratory findings On the Web |
American Roentgen Ray Society Images of Polycythemia laboratory findings |
Risk calculators and risk factors for Polycythemia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Debduti Mukhopadhyay, M.B.B.S[2]
Laboratory Findings
World Health Organization diagnostic criteria for Polycythemia Vera:[1]
- A1 Elevated RBC mass >25% above mean normal predicted value, or Hb>18.5g/dl in men, 16.5g/dl in women
- A2 No cause of secondary Erythrocytosis include absence of familial Erythrocytosis; no elevation of erythropoietin due to hypoxia (arterial PO2</= 92%), high oxygen affinity hemoglobin, truncated erythropoietin receptors, inappropriate erythropoietin production by tumor
- A3 Splenomegaly
- A4 Clonal genetic abnormality other than Ph chromosome or BCR/ABL fusion gene in marrow cells
- A5 Endogenous erythroid colony formation in vitro
- B1 Thrombocytosis >400x10ª/L
- B2 WBC >12x10ª/L
- B3 Bone marrow biopsy showing panmyelosiswith prominent erythroid and megakaryocytic proliferation
- B4 Low serum EPO levels
-Polycythemia diagnosed when A1 + A2 any other A or A1 + A2 + any other 2B. RBC indicated red blood cell; Hb, hemoglobin; Ph, Philadelphia; WBC, white blood cell; and EPO, erythropoietin.
References
- ↑ Cao M, Olsen RJ, Zu Y (2006). "Polycythemia vera: new clinicopathologic perspectives". Arch Pathol Lab Med. 130 (8): 1126–32. doi:10.1043/1543-2165(2006)130[1126:PV]2.0.CO;2. PMID 16879013.